Literature DB >> 16848675

Major depressive disorder, antidepressants, and sexual dysfunction.

Anita H Clayton1, Angel L Montejo.   

Abstract

Sexual dysfunction is a common problem with a number of causes, including psychosocial factors, general medical illness, psychiatric disorders, and psychotropic and nonpsychiatric medications. It is especially prevalent among patients with poor emotional health and has been strongly associated with antidepressant medications. Selective serotonin reuptake inhibitors (SSRIs) in particular have demonstrated a higher incidence of sexual dysfunction than other antidepressants that work through different mechanisms of action. Further supporting the relationship between sexual dysfunction and antidepressant mechanism of action, data from a number of studies indicate that bupropion, nefazodone, and mirtazapine alleviate symptoms of sexual dysfunction and are as effective as SSRIs at controlling depressive symptoms. Although a number of strategies besides drug substitution have been utilized to help manage antidepressant-induced sexual dysfunction, many patients remain suboptimally treated; as many as 42% of patients were found to passively wait for spontaneous remission. The addition of antidotal therapy has been proven to be among the effective management strategies for sexual dysfunction. However, due to a lack of systematic data, additional studies are warranted to further investigate these findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848675

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  18 in total

1.  Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine.

Authors:  Hatta Sidi; Duni Asmidar; Loh Huai Seng; Nik Ruzyanei Nik Jaafar; Marhani Midi; Ng Chong Guan
Journal:  Psychopharmacol Bull       Date:  2016-03-01

2.  Effects of bupropion on the ejaculatory response of male rats.

Authors:  M E Hueletl-Soto; M Carro-Juárez; G Rodríguez-Manzo
Journal:  Int J Impot Res       Date:  2014-05-01       Impact factor: 2.896

Review 3.  Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

Authors:  Christian Dolder; Michael Nelson; Andrea Stump
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

4.  The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.

Authors:  Angel L Montejo; Laura Montejo; David S Baldwin
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

5.  Positron emission tomography assessment of 8-OH-DPAT-mediated changes in an index of cerebral glucose metabolism in female marmosets.

Authors:  Alexander K Converse; Yves Aubert; Mohammed Farhoud; Jamey P Weichert; Ian J Rowland; Nicole M Ingrisano; Kelly A Allers; Bernd Sommer; David H Abbott
Journal:  Neuroimage       Date:  2012-01-02       Impact factor: 6.556

Review 6.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

7.  [Sexual dysfunction in remittent depressive women].

Authors:  A Baranyi; A Stepan; H-B Rothenhäusler
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

8.  HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse.

Authors:  Christina S Meade; Fiona S Graff; Margaret L Griffin; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2007-09-11       Impact factor: 4.492

9.  Sexual Function, Satisfaction, and Use of Aids for Sexual Activity in Middle-Aged Adults with Long-Term Physical Disability.

Authors:  Amanda E Smith; Ivan R Molton; Kara McMullen; Mark P Jensen
Journal:  Top Spinal Cord Inj Rehabil       Date:  2015-07-29

10.  Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.

Authors:  Merve Demirbugen Oz; Bora Baskak; Zuhal Uckun; Nazan Yuce Artun; Hatice Ozdemir; Tugba Kizil Ozel; Halise Devrimci Ozguven; H Sinan Suzen
Journal:  Pharmacogenomics J       Date:  2019-12-03       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.